Core Laboratories Q1 Revenue $121.8M, GAAP Loss $0.02, Ex-Items EPS $0.06
Core Laboratories reported Q1 revenue of $121.8 million, down 12% sequentially and flat year-over-year, with a GAAP loss of $0.02 per share and adjusted EPS of $0.06. Operating income totaled $1.9M GAAP and $6.6M ex-items, net debt rose $3.9M and the company repurchased 51,781 shares for $0.9M.
1. First Quarter Financial Results
First quarter revenue totaled $121.8 million, marking a 12% sequential decline and flat year-over-year performance. GAAP operating income was $1.9 million with a $0.02 per share loss, while non-GAAP operating income reached $6.6 million with $0.06 adjusted EPS.
2. Geopolitical and Operational Headwinds
Operational disruptions from Middle East geopolitical conflict, Russia-Ukraine tensions and severe weather across North America and Europe weighed on client projects, sample acquisition and product deliveries, impacting both reservoir description and production enhancement services.
3. Balance Sheet and Capital Returns
The company’s net debt rose by $3.9 million, yielding a leverage ratio of 1.20. Management repurchased 51,781 shares for $0.9 million and declared a quarterly dividend for Q2, underlining its commitment to returning capital to shareholders.